Anti-CD11+CD18 antibody [24]
4
(5 Reviews)
|
(28 Publications)
Mouse Monoclonal ITAL antibody. Suitable for ICC/IF, IP, Flow Cyt, WB, RIA and reacts with Human, Dog, Mouse, Rat samples. Cited in 28 publications. Immunogen corresponding to Cell preparation containing ITGB2 protein.
View Alternative Names
CD11a, CD11A, ITGAL, Integrin alpha-L, CD11 antigen-like family member A, Leukocyte adhesion glycoprotein LFA-1 alpha chain, Leukocyte function-associated molecule 1 alpha chain, LFA-1A, CD18, MFI7, ITGB2, Integrin beta-2, Complement receptor C3 subunit beta
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD11a/CD18 enables leukocyte adhesion to endothelial cells and guides their migration towards sites of inflammation. It functions as part of a larger integrin family responsible for various cellular processes. The protein complex binds to its ligand ICAM-1 (Intercellular Adhesion Molecule 1) initiating a cascade of signaling events that facilitate immune surveillance and cell junction formation. This adhesion complex is integral to the regulation of immune system functions.
Pathways
CD11a and CD18 participate in the leukocyte extravasation pathway which is important for trafficking immune cells to areas of injury or infection. The protein complex also interacts within the T-cell receptor signaling pathway assisting in T-cell activation and proliferation. It works alongside proteins such as ICAM-1 to maintain cellular communication and adhesion allowing for a coordinated immune response. The involvement of CD11+CD18 in these pathways highlights its role in mediating inflammatory responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (28)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eadq8114 PubMed39792660
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular research 119:1811-1824 PubMed37279540
2023
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 16:3677-3689 PubMed36277599
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 20:189 PubMed36002835
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 20:218 PubMed35525963
2022
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 16:e0260835 PubMed34882718
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 10:245-258 PubMed34819308
2021
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 11:5248-5266 PubMed33859745
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:594775 PubMed33424843
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of controlled release : official journal of the Controlled Release Society 330:101-110 PubMed33333118
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com